Search Results - Diaz‐Beveridge, Roberto

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial by Maio, Michele, Lewis, Karl, Demidov, Lev, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Cinat, Gabriela, Brown, Michael, Guminski, Alexander, Haydon, Andrew, Khattak, Adnan, McNeil, Catriona, Power, Jeremy, Roberts-Thomson, Rachel, Underhill, Craig, Berger, Thomas, Awada, Ahmad, Blockx, Nathalie, Buyse, Veronique, Mebis, Jeroen, Franke, Fábio André, Jobim de Azevedo, Sérgio, Silva Lazaretti, Nicolas, Mihalcioiu, Catalin, Petrella, Teresa, Song, Xinni, Wong, Ralph, Dabelic, Nina, Plestina, Stjepko, Vojnovic, Zeljko, Kocak, Ivo, Krajsova, Ivana, Kubala, Eugen, Melichar, Bohuslav, Dutriaux, Caroline, Joly, Pascal, Lacour, Jean-Philippe, Meyer, Nicolas, Mortier, Laurent, Fluck, Michael, Hassel, Jessica, Hauschild, Axel, Donnellan, Paul, McCaffrey, John, Power, Derek, Ariad, Samuel, Bar-Sela, Gil, Ron, Ilan, Schachter, Jacob, Berruti, Alfredo, Bianchi, Luca, Chiarion Sileni, Vanna, Cognetti, Francesco, Danielli, Riccardo, Di Giacomo, Anna Maria, Gianni, Luca, Goldhirsch, Aron, Guida, Michele, Maio, Michele, Mandalà, Mario, Marchetti, Paolo, Santoro, Armando, Kapiteijn, Ellen, Mackiewicz, Andrzej, Rutkowski, Piotr, Ferreira, Paula, Demidov, Lev, Gafton, Georgy, Makarova, Yulia, Jovanovic, Darjana, Kandolf Sekulovic, Lidija, Curiel Garcia, Maria Teresa, Majem Tarruella, Margarita, Marquez Rodas, Ivan, Puliats Rodriguez, Jose-M, Papworth, Karin, Bondarenko, Igor, Corrie, Pippa, Harries, Mark, Herbert, Christopher, Middleton, Mark, Patel, Poulam, Talbot, Toby, Agarwala, Sanjiv, Chapman, Paul, Conry, Robert, Doolittle, Gary, Gangadhar, Tara, Hallmeyer, Sigrun, Kass, Frederic, Lewis, Karl, Salama, April, Sikic, Branimir, Spigel, David, Whitman, Eric

    Published in The lancet oncology
    Get full text
    Article
  18. 18
  19. 19
  20. 20